Peter M Kash's Net Worth
$6.48 Million
Who is Peter M Kash?
Peter M Kash has an estimated net worth of $6.48 Million. This is based on reported shares across multiple companies, which include DENALI SCIENCES, INC., Arno Therapeutics, Inc, INTRAC INC, Nile Therapeutics, Inc., and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Peter M Kash's CIK is 0001253023
Past Insider Trading and Trends
2006 was Peter M Kash's most active year for acquiring shares with 9 total transactions. Peter M Kash's most active month to acquire stocks was the month of November. 2004 was Peter M Kash's most active year for disposing of shares, totalling 1 transactions. Peter M Kash's most active month to dispose stocks was the month of December. 2006 saw Peter M Kash paying a total of $983,522.57 for 332,935 shares, this is the most they've acquired in one year. In 2006 Peter M Kash cashed out on 26,575 shares for a total of $107,628.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DENALI SCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arno Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTRAC INC No price found
InvestorPeter M Kash owns 464,328 units of Common Stock and 396,572 units of Common stock, $.001 par value. In the year 2005 Peter M Kash filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
| +1.28% | 5K |
$3.65 | $18,243.36 | 396.57K |
Nov 29
| |||
Form 4
| +0.03% | 100 |
$3.00 | $300.00 | 391.57K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +2.20% | 10K |
$3.20 | $32,000.00 | 464.33K |
Nov 7 - Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nile Therapeutics, Inc. (CAPR) Snapshot price: $4.09
InvestorPeter M Kash owns 1,596,208 units of Common Stock which is worth $6,528,490.72.acquired a total of 103,414 shares in Nile Therapeutics, Inc. at a cost of $5,483.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
| +6.60% | 98.81K |
—
|
—
| 1.6M |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
| +0.31% | 4.6K |
$1.19 | $5,483.00 | 1.5M |
Dec 11 - Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
InvestorPeter M Kash owns 760,750 units of Common Stock. In the year 2004 Peter M Kash filed a total of 1 filing.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.62% | -120.00K |
$0.10 | -$12,000.00 | 760.75K |
Jan 29
| |||
| No matching records found | |||||||||